The promise of immunostimulatory antibodies in head and neck cancer

Lancet Oncol. 2016 Jul;17(7):856-857. doi: 10.1016/S1470-2045(16)30106-1. Epub 2016 May 27.

Authors

Jean-Pascal H Machiels¹, Pierre G Coulie²

Affiliations

¹ Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain, 1200 Brussels, Belgium. Electronic address: jean-pascal.machiels@uclouvain.be.
² de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

PMID: 27247227
DOI: 10.1016/S1470-2045(16)30106-1

No abstract available

Publication types

Comment

MeSH terms

Antibodies
Antibodies, Monoclonal
Carcinoma, Squamous Cell / immunology*
Head and Neck Neoplasms*
Humans

Substances

Antibodies
Antibodies, Monoclonal